CRON Q3 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q3 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+38.1% YoY

Gross Profit

$4M15.4% margin

Operating Income

-$38M-133.9% margin

Net Income

-$51M-181.2% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$64M

Stockholders' Equity

$1.6B

Cash & Equivalents

$875M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$20M	+38.1%
Gross Profit	$4M	-$730,000	+694.8%
Operating Income	-$38M	-$56M	+33.1%
Net Income	-$51M	$78M	-165.6%

Revenue Segments

Cannabis Flower

$14M65%

Cannabis Extracts

$7M34%

Product and Service, Other

$108,0001%

Geographic Segments

CANADA

$13M64%

ISRAEL

$7M34%

UNITED STATES

$514,0002%